Targeted therapy of TERT-rearranged neuroblastoma with BET bromodomain inhibitor and proteasome inhibitor combination therapy

- Chen, Jingwei, Nelson, Christopher, Wong, Matthew, Tee, Andrew E., Liu, Pei Y., La, Ting, Fletcher, Jamie I., Kamili, Alvin, Mayoh, Chelsea, Bartenhagen, Christoph, Trahair, Toby N., Xu, Ning, Jayatilleke, Nisitha, Wong, Marie, Peng, Hui, Atmadibrata, Bernard, Cheung, Belamy B., Lan, Qing, Bryan, Tracy M., Mestdagh, Pieter, Vandesompele, J, Combaret, V, Boeva, V, Wang, JY, Janoueix-Lerosey, I, Cowley, MJ, MacKenzie, KL, Dolnikov, A, Li, J, Polly, P, Marshall, GM, Reddel, RR, Norris, MD, Haber, M, Fischer, M, Zhang, Xu D., Pickett, HA, Liu, T

The emerging roles of rna m6a methylation and demethylation as critical regulators of tumorigenesis, drug sensitivity, and resistance

- Lan, Qing, Liu, Pei Y., Bell, Jessica L., Wang, Jenny Y., Hüttelmaier , Stefan, Zhang, Xu Dong, Zhang, Lirong, Liu, Tao

JMJD6 is a tumorigenic factor and therapeutic target in neuroblastoma

- Wong, Matthew, Sun, Yuting, Xi, Zhichao, Milazzo, Giorgio, Poulos, Rebecca C., Bartenhagen, Christoph, Bell, Jessica L., Mayoh, Chelsea, Ho, Nicholas, Tee, Andrew E., Chen, Xiaoqiong, Li, Yang, Ciaccio, Roberto, Liu, Pei Y., Jiang, Chen C., Lan, Qing, Jayatilleke, Nisitha, Cheung, Belamy B., Haber, Michelle, Norris, Murray D., Zhang, Xu D., Marshall, GM, Wang, JY, Huettelmaier, S, Fischer, M, Wong, JWH, Xu, H, Perini, G, Dong, Q, George, RE, Liu, T

The long noncoding RNA lncNB1 promotes tumorigenesis by interacting with ribosomal protein RPL35.

- Liu, Pei Y., Tee, Andrew E., Milazzo, Giorgio, Hannan, Katherine M., Maag, Jesper, Mondal, Sujanna, Atmadibrata, Bernard, Bartonicek, Nenad, Peng, Hui, Ho, Nicholas, Mayoh, Chelsea, Ciaccio, Roberto, Sun, Yuting, Henderson, Michelle J., Gao, Jixuan, Everaert, Celine, Hulme, Amy J., Wong, Matthew, Lan, Qing, Cheung, Belamy B., Zhang, Xu D.